https://www.avient.com/sites/default/files/2023-08/AVNT August IR Presentation w NonGAAP Recs%5B40%5D.pdf
W H AT W E D O : W E A R E A F O R M UL ATO R
6
CUSTOM
FORMULATION
J U LY 2 7 , 2 0 2 3
W E B C A S T
P R E S E N TA T I O N
COMPOSI TES PORTF OL IO
D Y N E E M A ® E X P A N D S O U R E N G I N E E R E D F I B E R S A N D P A N E L S
T E C H N O L O G Y
LFT Tapes Laminates/Panels Shapes Pultrusion Engineered Fibers
8
DEFENSE TELECOMMUNICATIONS ENERGY TRANSPORTATION
Military • Law Enforcement
First Responders
Body Armor • Helmets
Vehicle Protection
Sustainable Infrastructure
Offshore Wind
Electrical Grid Protection
EV Battery Components
Commercial Laminates
Body & Trim • Air Cargo and
Railroad Car Panels
5G Applications
Fiber Optic Cables
Satellite Communications
Connectors and
Components
9
COMPOSI TES SERVE D IV ER SIF IED
END MAR KETS
INDUSTRIAL
Lifting Slings • Aquaculture
High Pressure Pipe
Conveyer Springs
Q 2 P E R F O R M A N C E
Q2 2023 PERFORMANCE VS.
Avient reflects 2023 adjusted EBITDA guidance of $525M and estimated run-rate CAPEX of $110M.
2023E (%)
27
79
89
83 83
78
75
90
81
76
72
68
63
53
11
A
vi
e
n
t
K
W
R
F
U
L
P
P
G
A
V
Y
R
P
M
F
M
C
C
E
E
C
L
A
S
H
H
X
L
H
U
N
E
M
N
S
C
L
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
MULTI PL E EX PANSION
Source: Peer data per Bloomberg as of August 17, 2023
Note: Avient reflects 2023 adjusted EBITDA guidance of $525M and closing share price of $37.07.
Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years.
28
EV / 2023E EBITDA
Historic Multiple
6.5
8.3
9.5
13.8
12.7 12.6
11.3
8.7
18.6
16.5
10.1 10.0 9.7 9.5 9.4
8.7
A
vi
e
n
t
(2
0
1
1
)
A
vi
e
n
t
(2
0
1
8
)
A
vi
e
n
t
(2
0
2
3
)
R
P
M
P
P
G
A
V
Y
K
W
R
F
U
L
E
C
L
H
X
L
F
M
C
A
S
H
S
C
L
H
U
N
C
E
E
M
N
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
SEGMENT DATA
U.S. & Canada
40%
EMEA
37%
Asia
18%
Latin America
5%
2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY
GEOGRAPHY REVENUESEGMENT FINANCIALS
Consumer
20%
Packaging
24%
Industrial
15%
Building and
Construction
10%
Telecommunications
4%
Energy
4%
Defense
6%
END MARKET REVENUE
$2,355M $402M
$1,300M $272M
Sales EBITDA
Specialty Engineered Materials
Color Additives and Inks
$592M$3,653M
(1)
Transportation
9%
Healthcare
8%
30
(1) Total company sales and adjusted EBITDA of $3,653M and $592M, respectively, include intercompany sales eliminations and corporate costs
2 0 2 2 R E V E N U E | $ 2 . 4 B I L L I O N
US & Canada
34%
EMEA
38%
Asia
20%
Latin America
8%
END MARKET REGION
31
Packaging
34%
Consumer
21%
Healthcare
8%
Industrial
15%
Transportation
8%
Building &
Construction
11%
Telecommunications
1% Energy
2%
COLOR , AD DI TI VES & INKS
2 0 2 2 P R O F O R M A R E V E N U E | $ 1 . 3 B I L L I O N
US & Canada
52%
EMEA
35%
Asia
13%
32
Packaging
5%
Consumer
19%
Healthcare
8%Industrial
16%
Transportation
10%
Telecommunications
10%
Energy
9% Defense
15%
Building &
Construction
8%
END MARKET REGION
SPEC IA LTY ENGI NEER ED MATERI ALS
Packaging
32%
Consumer
27%
Healthcare
8%
Industrial
14%
Building &
Construction
5%
Telecommunications
3%
Energy
1% Defense
1%
Asia
(18% of sales)
Transportation
9%
2 0 2 2 P R O F O R M A AV I E N T R E G I O N A L S A L E S
Packaging
27%
Consumer
14%
Healthcare
5%
Industrial
17%
Building &
Construction
10%
Energy
5%
Defense
8%
EMEA
(37% of sales)Transportation
11%
Packaging
13%
Consumer
24%
Healthcare
12%
Industrial
15%
Building &
Construction
13%
Energy
5%
Defense
5%
US &
Canada
(40% of sales)
Transportation
7%
Packaging
56%
Consumer
23%
Healthcare
4%
Industrial
7%
Building &
Construction
4%
Telecommunications
1%
LATAM
(5% of sales)
Transportation
5%
Telecommunications
3%
Telecommunications
6%
33
B Y E N D M A R K E T
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.